SILK logo

Silk Road Medical, Inc Stock Price

NasdaqGS:SILK Community·US$1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SILK Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

SILK Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet very low.

2 Risks
1 Reward

Silk Road Medical, Inc Key Details

US$191.4m

Revenue

US$49.2m

Cost of Revenue

US$142.2m

Gross Profit

US$198.7m

Other Expenses

-US$56.5m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-1.39
74.28%
-29.53%
49.2%
View Full Analysis

About SILK

Founded
2007
Employees
474
CEO
Charles McKhann
WebsiteView website
silkroadmed.com

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Recent SILK News & Updates

Recent updates

No updates